The company states: Enveric Biosciences (ENVB) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent application pertaining to its EVM301 Series of molecules being developed as potential treatments for mental health disorders. The USPTO issues a Notice of Allowance after making the determination that a patent should be granted from an application.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue